SILO
Silo Pharma·NASDAQ
--
--(--)
--
--(--)
7.39 / 10
Outperform
Money flow analysis registers a strong 7.39/10, driven by positive large-cap inflows, despite negative trends in other sizes. The absence of analyst coverage (-1) means sentiment is primarily driven by fund flows and news, creating an uneven information landscape.
Fund Flow Rating
Is money flowing into or out of SILO?
- SILO holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.39/10 (Outperform).
